Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

Alessandro Grattoni(Houston Methodist), Paul de Vos(Zuyd University of Applied Sciences), Camillo Ricordi(Miami Transplant Institute), Holger A. Russ(Tel Aviv University), Marjana Marinac(Unknown), Michael A. Brehm(University of Massachusetts Chan Medical School), Michael V. Sefton(University of Toronto), Antonio Citro(Apple (Israel)), Minglin Ma(Cornell University), Klearchos K. Papas(University of Arizona), Norma S. Kenyon(University of Miami), Omid Veiseh(Rice University), M. Cristina Nostro(University of Toronto), Tejal A. Desai(Brown University), Haval Shirwan(Cancer Research Center), Nicholas E. Mamrak(Breakthrough), Alice A. Tomei(Vrije Universiteit Brussel), Jon S. Odorico(University of Wisconsin–Madison), Andrew R. Pepper(University of Alberta), Qizhi Tang(Gladstone Institutes), Megan Sykes(Columbia University Irving Medical Center), Mark C. Poznansky(Harvard University), Esther Latres(Unknown), Juan M. Melero‐Martin(Boston Children's Hospital), Melanie L. Graham(University of Minnesota), Cherie L. Stabler(University of Miami), Jeffrey R. Millman(Washington University in St. Louis), Andrés J. Garcı́a(Georgia Institute of Technology), Jaime A. Giraldo(Breakthrough), Gregory S. Korbutt(University of Alberta)
Nature Reviews Endocrinology
September 3, 2024
Cited by 84


Related Papers